Retrovirus-mediated suicide gene transduction in the vitreous cavity of the eye: Feasibility in prevention of proliferative vitreoretinopathy

Human Gene Therapy

Volumn 7, Issue 7, 1996, Pages 799-808

  Kimura, Hideya ^a   Sakamoto, Taiji ^a   Cardillo, Jose A ^a   Spee, Christine ^a   Hinton, David R ^a   Gordon, Erlinda M ^a   Anderson, W French ^a   Ryan, Stephen J ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b DOHENY EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; THYMIDINE KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXPRESSION VECTOR; FEMALE; FIBROBLAST; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; HERPES SIMPLEX VIRUS; MALE; NONHUMAN; RABBIT; REPORTER GENE; RETROVIRUS; VITREORETINOPATHY; VITREOUS BODY;

EID: 0029928282     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1996.7.7-799     Document Type: Article

References (40)

1. BENNETT, J., WILSON, J., SUN, D., FORBES, B., and MAGUIRE, A. (1994). Adenovirus vector-mediated in vivo gene transfer into adult murine retina. Invest Ophthalmol. Vis. Sci. 35, 2535-2542.
2. BI, W.L., PARYSEK, L.M., WARNICK, R., and STAMBROOK, P.J. (1993). In vivo evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gene therapy. Hum. Gene Ther. 4, 725-731.
3. BOVIATSIS, E.J., CHASE, E.J., WEI, M.X., TAMIYA, T. HURFORD, R.K., KOWALL, N.W., TEPPER, R.I., BREAKEFIELD, X.O., and CHIOCCA, E.A. (1994). Gene transfer into experimental brain tumors mediated by adehovirus, herpes simplex virus, and retrovirus vectors. Hum. Gene Ther. 5, 183-191.
4. BUDENZ, D.L., BENNETT, J., ALOMSO, L., and MAGUIRE, A. (1995). In vivo gene transfer into murine trabecular meshwork and corneal endothelial cells. Invest Ophthalmol. Vis. Sci. 36 (4, suppl.), S846.
5. CHANDLER, D.B., QUANSAH, F.A., HIDA, T., and MACHEMER, R. (1986). A refined experimental model for proliferative vitreoretinopathy. Graefe's Arch. Clin. Exp. Ophthalmol. 224, 86-91.
6. CORNETTA, K., MOEN, R.C., CULVER, K., MORGAN, R.A., McLACHLIN, J.R., STUM, S., SELEGUE, J., LONDON, W., BLAESE, R.M., and ANDERSON, W.F. (1990). Amphotropic murine leukemia retrovirus is not an acute pathogen for primates. Hum. Gene Ther. 1, 15-30.
7. CULVER, K.W., RAM, Z., WALLBRIDGE, S., ISHII, H., OLDFIELD, E.H., and BLAESE, R.M. (1992). In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 256, 1550-1552.
8. FASTENBERG, D.M., DIDDIE, K.R., DOREY, K., and RYAN, S.J. (1982). The role of cellular proliferation in an experimental model of massive periretinal proliferation. Am. J. Ophthalmol. 93, 565-572.
9. FERRY, N., DUPLESSIS, O., HOUSSIN, D., DANOS, O., and HEARD, J.M. (1991). Retroviral-mediated gene transfer into hepatocytes in vivo. Proc. Natl. Acad. Sci. USA 88, 8377-8381.
10. FIELD, A.K., DAIES, M.E., DEWITT, C., PERRY, H.C., and LIOU, R. (1983). 9-{[2-hydroxy-1-(hydroxymethyl)-ethoxy]methyl}guanine: a selective inhibitor of herpes group virus replication. Proc. Natl. Acad. Sci. USA 80, 4139-4143.
11. FREEMAN, S.M., ABBOUD, C.N., WHARTENBY, K.A., PACKMAN, C.H., KOEPLIN, D.S., MOOLTEN, F.L., and ABRAHAM, G.N. (1993). The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res. 53, 5274-5283.
12. GLASER, B.M., and LEMOR, M. (1994). Pathobiology of proliferative vitreoretinopathy. In Retina. S.J. Ryan, eds. (St. Louis, Mosby Year Book, St. Louis, MO) pp. 2249-2263.
13. HAUSWIRTH, W.W., ZOLOTUKHIN, S., MUZYCZKA, N., and FLANNERY, J.G. (1995). Adeno-associated virus delivery of an opsin promoter driven reporter gene to the mouse and rabbit retina. Invest. Ophthalmol. Vis. Sci. 36 (4, suppl.), S845.
14. HEINEMANN, M.H. (1989). Long-term intravitreal ganciclovir therapy for cytomegalovirus retinopathy. Arch. Ophthalmol. 107, 1767-1772.
15. HENRY, K., CANTRILL, H., FLETCHER, C., CHINNOCK, B.J., and BALFOUR, H.H., JR (1987). Use of intravitreal ganciclovir (dihydroxy propoxymethyl guanine) for cytomegalovirus retinitis in a patient with AIDS. Am. J. Ophthalmol. 103, 17-23.
16. HIDA T., CHANDLER, D.B., and SHETA, S.M. (1987). Classification of the stages of proliferative vitreoretinopathy in a refined experimental model in the rabbit eye. Graefe's Arch. Clin. Exp. Ophthalmol. 225, 303-307.
17. JABS, D.A., NEWMAN, C., DE BUSTROS, S., and POLK, B.F. (1987). Treatment of cytomegalovirus retinitis with ganciclovir. Ophthalmology 94, 824-830.
18. LI, T., ADAMIAN, M., ROOF, D.J., BERSON, E.L., DRYJA, T.P., ROESSLER, B.J., and DAVIDSON, B.L. (1994). In vivo transfer of a reporter gene to the retina mediated by an adenoviral vector. Invest. Ophthalmol. Vis. Sci. 35, 2543-2549.
19. MILLER, D.G., ADAM, M.A., and MILLER, A.D. (1990). Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol. Cell. Biol. 10, 4239-4242.
20. MILLER, F.R., MCEACHERN, D., and MILLER, B.E. (1990). Efficiency of communication between tumor cells in collagen cultures. Br. J. Cancer 62, 360-363.
21. MOOLTEN, F.L., and WELLS, J.M. (1990). Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors. J. Natl. Canc. Inst. 82, 297-300.
22. MOOLTEN, F.L., WELLS, J.M., HEYMAN, R.A., and EVANS, R.M. (1990). Lymphoma regression induced by ganciclovir in mice bearing a herpes thymidine kinase transgene. Hum. Gene Ther. 1, 125-134.
23. PEPOSE, J.S., and LEIB, D.A. (1994). Herpes simplex viral vectors for therapeutic gene delivery to ocular tissues: Recent breakthroughs in the molecular genetics of ocular diseases. Invest. Ophthalmol. Vis. Sci. 35, 2662-2666.
24. PLAUTZ, G., NABEL, E.G., and NABEL, G.J. (1991). Selective elimination of recombinant genes in vivo with a suicide retroviral vector. New Biol. 3, 709-715.
25. PULIDO, J., PEYMAN, G.A., LESAR, T., and VERNT, J. (1985). Intravitreal toxicity of hydroxyacyclovir (BW-B759U), a new antiviral agent. Arch. Ophthalmol. 103, 840-841.
26. RAM, Z., CULVER, K.W., WALBRIDGE, S., BLAESE, R.M., and OLDFIELD, E.H. (1993). In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. Cancer Res. 53, 83-88.
27. RAM, Z., WALBRIDGE, S., SHAWKER, T., CULVER, K.W., BLAESE, R.M., and OLDFIELD, E.H. (1994). The effect of thymidine kinase transduction and ganciclovir therapy on tumor vasculature and growth of 9L gliomas in rats. J. Neurosurg. 81, 256-260.
28. RETTINGER, S.D., PONDER, K.P., SAYLORS, R.L., KENNEDY, S.C., HAFENRICHTER, D.G., and FLYE, M.W. (1993). In vivo hepatocyte transduction with retrovirus during in-flow occlusion. J. Surg. Res. 54, 418-425.
29. RETTINGER, S.D., KENNEDY, S.C., WU, X., SAYLORS, R.L., HAFENRICHTER, D.G., FLYE, M.W., and PONDER, K.P. (1994). Liver-directed gene therapy: Quantitative evaluation of promoter elements by using in vivo retroviral transduction. Proc. Natl. Acad. Sci. USA 91, 1460-1464.
30. ROEHM, N.W., RODGERS, G.H., HATFIELD, S.M., and GLASEBROOK, A.L. (1991). An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT. J. Immunol. Methods. 142, 257-265.
31. ROZGA, J., MOSCIONI, A.D., NEUZIL, D., and DEMETRIOU, A.A. (1992). A model for directed foreign gene delivery to rat liver cells in vivo. J. Surg. Res. 52, 209-213.
32. SAKAMOTO, T., KIMURA, H., SCURIC, Z., SPEE, C., GORDON, E.M., HINTON, D.R., ANDERSON, W.F., and RYAN, S.J. (1995). Inhibition of experimental proliferative vitreoretinopathy by retroviral vector-mediated gene transfer of suicide gene: Can PVR be a target of gene therapy? Ophthalmology 102, 1417-1424.
33. SCHULMAN, J., PEYMAN, G.A., HORTON, M.B., LIU, J., FISCELLA, R., PULIDO, J., BARBER, J.C., and DE MIRANDA, P. (1986). Intraocular 9- ([2-hydroxy-1-(hydroxymethyl) ethoxy] methyl) guanine levels after intravitreal and subconjunctival administration. Ophthalmic Surg. 17, 429-432.
34. SCUDIERO, D.A., SHOEMAKER, R.H., PAULL, K.D., MONKS, A., TIRNEY, S., NOFZIGER, T.H., CURRENS, M.J., SENIFF, D., and BOYD, M.R. (1988). Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res. 48, 4827-4833.
35. SHAKED, A., CSETE, M.E., SHIRAISHI, M., MILLER, A.R., MOEN, R.C., BUSUTTIL, R.W., and ECONOMOU, J.S. (1994). Retroviral-mediated gene transfer into rat experimental liver transplant. Transplantation 57, 32-34.
36. SMITH, K.O., GALLOWAY, K.S., KENNELL, W.L., OGILVIE, K.K., and RADATUS, B.K. (1982). A new nucleoside analog, 9-{[2-hydroxyl-1-(hydroxymethyl)-ethoxyl]methyl}guanine, highly active in vitro against herpes simplex virus types 1 and 2. Antimicrob. Agents Chemother. 22, 55-61.
37. TANABE, T., GOURAS, P., BENNETT, J., and KJELDBYE, H. (1995). Gene therapy slows the retinal degeneration in rd mice. Invest. Ophthalmol. Vis. Sci. 36 (4, suppl.), S845.
38. WELSH, R.M.J., JENSEN, F.C., COOPER, N.R., and OLDSTONE, M.B.A. (1976). Inactivation and lysis of oncomaviruses by human serum. Virology 74, 432-440.
39. WIEDEMANN, P., RYAN, S.J., NOVAK, P., and SORGENTE, N. (1985). Vitreous stimulates proliferation of fibroblasts and retinal pigment epithelial cells. Exp. Eye Res. 41, 619-628.
40. WU, J.K., CANO, W.G., MEYLAERTS, S.A.G., QI, P., VRIONIS, F., and CHERINGTON, V. (1994). Bystander tumoricidal effect in the treatment of experimental brain tumors. Neurosurgery 35, 1094-1103.